^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ATG-027

    i
    Other names: ATG-027
    Associations
    News
    Trials
    Company:
    Antengene
    Drug class:
    PD-L1 inhibitor, B7-H3 inhibitor
    Related drugs:
    Associations
    News
    Trials